A clinical trial of the anti-malaria drug hydroxychloroquine in coronavirus patients has been suspended amid safety concerns.
The drug has been touted by President Donald Trump and he even revealed he took the medication for two weeks as a prophylactic.
But the World Health Organization (WHO) said it was concerned after a study from The Lancet published on Friday revealed higher mortality rates among COVID-19 patients who took the drug.
Therefore, researchers said they’re suspending the use of hydroxychloroquine in the WHO’s Solidarity Trial, which is to evaluate the safety and efficacy of four drugs and drug combinations against the virus.
‘The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board,’ WHO Director-General Tedros Adhanom Ghebreyesus said on Monday.
However, the other arms of the trial are continuing.
A Nigerian lady has tied the knot with a man she met online by chance after using a VPN to… Read More
Wizkid Breaks Streaming Records with Latest Single "Kese" on Spotify Afrobeats superstar Wizkid has set a new milestone with his… Read More
The Abuja Division of the Appeal Court has formally dismissed Musiliu Akinsanya, also known as MC Oluomo, from his position… Read More
DJ Chicken, is in the news after his trip to the United Kingdom. He shared the exciting update by posting… Read More
Daniel Regha has criticized Buju BXN for his behavior towards a Davido fan. This started after rumors spread that Buju… Read More
Iyabo Ojo is making headlines after sharing her thoughts on the death of Mohbad. Mohbad passed away in Lagos on… Read More
This website uses cookies.